Page last updated: 2024-08-24

rhodamine 123 and Disease Exacerbation

rhodamine 123 has been researched along with Disease Exacerbation in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andelković, T; Banković, J; Pešić, M; Podolski-Renić, A; Ruždijić, S; Tanić, N1
Benoit, Y; De Moerloose, B; Demarche, M; Devalck, C; Dhooge, C; Laureys, G; Leroy, J; Philippé, J; Plantaz, D1

Other Studies

2 other study(ies) available for rhodamine 123 and Disease Exacerbation

ArticleYear
The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2011, Volume: 65, Issue:5

    Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Cycle; Cell Death; Cell Line, Tumor; Colonic Neoplasms; Disease Progression; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glioblastoma; Glutathione; Humans; Inactivation, Metabolic; Paclitaxel; Rhodamine 123; RNA, Messenger; Vascular Endothelial Growth Factor A

2011
Discrepant flow cytometric expression and function of P-glycoprotein in neuroblastic tumors.
    Cytometry, 1999, Oct-01, Volume: 37, Issue:2

    Topics: Adolescent; Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Child; Child, Preschool; Disease Progression; Female; Flow Cytometry; Ganglioneuroma; Humans; Immunohistochemistry; Infant; Infant, Newborn; Leukocyte Common Antigens; Male; Neoplasm Proteins; Neuroblastoma; Rhodamine 123; Tumor Cells, Cultured

1999